CWM
PAVM icon

CarsonAllaria Wealth Management’s PAVmed PAVM Stock Holding History

CarsonAllaria Wealth Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$449 – 396
2023
Q2 		$449 Hold
2
– – ﹤0.01% 373
2023
Q1 		$411 Hold
2
– – ﹤0.01% 360
2022
Q4 		$1K Hold
2
– – ﹤0.01% 325
2022
Q3 		$1K Hold
2
– – ﹤0.01% 320
2022
Q2 		$1K Buy
2
+1
+100% +$483 ﹤0.01% 316
2022
Q1 		$0 Sell
1
-1
-50% -$743 ﹤0.01% 354
2021
Q4 		$3K Buy
+2
New +$4.35K ﹤0.01% 301

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

CarsonAllaria Wealth Management's PAVM Position: Q3 2023 in Review

CarsonAllaria Wealth Management sold out of PAVmed (PAVM) in Q3 2023, closing a stake of 2 shares — an estimated $449 sold.

CarsonAllaria Wealth Management first reported a position in PAVM in Q4 2021 and held it in 7 quarters. The position peaked at $3K in Q4 2021. 60 funds tracked by Wall St. Rank hold PAVM as of Q3 2023.

  • CarsonAllaria Wealth Management reported no remaining PAVmed position as of Q3 2023 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 2 PAVmed shares in Q3 2023, an estimated $449.
  • CarsonAllaria Wealth Management first reported a position in PAVmed in Q4 2021 and held it in 7 quarters.
  • CarsonAllaria Wealth Management's PAVmed position peaked at $3K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held PAVmed as of Q3 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2023, filed 9 Nov 2023.